Skip to main content

Bolt Biotherapeutics, Inc.

BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001641281

In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 3 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.

Holders of 5% or more of BOLT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bolt Biotherapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BOLT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Coastlands Capital LP13G17.50%412.4K sharesNewNov 6, 20261 filingNov 6, 2026SEC
Tang Capital Management LLC13G/A9.90%3.81M shares–May 15, 20251 filingMay 15, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

33 Schedule 13D and 13G filings on Bolt Biotherapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BOLT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 12, 20263:35 PM ETRenaissance Technologies LLCand 1 other13G/A4.82%92.9K shares−0.31 ppfrom 5.13%Below 5%Sep 30, 2026SEC
Nov 6, 20266:05 PM ETCoastlands Capital LPand 4 others13G17.50%412.4K sharesNewOct 30, 2026SEC
Aug 13, 20264:20 PM ETRenaissance Technologies LLCand 1 other13G5.13%98.6K sharesNewJun 24, 2026SEC
Feb 26, 20267:22 PM ETPivotal bioVenture Partners Fund I, L.P.and 10 others13D/A4.60%87.5K shares−2.10 ppfrom 6.70%Below 5%Feb 24, 2026SEC
Feb 17, 20268:11 PM ETPivotal bioVenture Partners Fund I, L.P.and 10 others13D/A6.70%128.1K shares–Feb 5, 2026SEC
Feb 13, 20266:48 PM ETVivo Panda Fund, L.P.and 4 others13G/A3.80%72.4K shares–Below 5%Dec 31, 2025SEC
Nov 14, 20254:17 PM ETTang Capital Management LLCand 5 others13G/A3.50%66.9K shares0.00 ppfrom 3.50%Below 5%Sep 30, 2025SEC
Nov 14, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A3.50%66.9K shares−5.20 ppfrom 8.70%Below 5%Sep 30, 2025SEC
Aug 14, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A8.70%166.9K shares–Jun 30, 2025SEC
May 15, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A9.90%3.81M shares–Mar 31, 2025SEC
Nov 14, 2024Citadel Advisors LLC13G/AOld format–––SEC
Feb 14, 2024Tang Capital Partners LP13G/AOld format–––SEC
Feb 14, 2024Citadel Advisors LLC13G/AOld format–––SEC
Feb 13, 2024Vivo Capital VIII, LLC13G/AOld format–––SEC
Feb 12, 2024Pivotal bioVenture Partners Fund I, L.P.13D/AOld format–––SEC
Apr 20, 2023Tang Capital Partners LP13GOld format–New–SEC
Feb 14, 2023Citadel Advisors LLC13G/AOld format–––SEC
Feb 13, 2023Suvretta Capital Management, LLC13G/AOld format–––SEC
Jan 4, 2023Novo Holdings A/S13D/AOld format–––SEC
Dec 28, 2022Novo Holdings A/S13D/AOld format–––SEC
Sep 30, 2022Novo Holdings A/S13D/AOld format–––SEC
Jul 15, 2022Novo Holdings A/S13D/AOld format–––SEC
May 16, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022Citadel Advisors LLC13G/AOld format–––SEC
Nov 29, 2021Suvretta Capital Management, LLC13GOld format–New–SEC
Nov 22, 2021Novo Holdings A/S13D/AOld format–––SEC
Aug 13, 2021Pivotal bioVenture Partners Fund I, L.P.13D/AOld format–––SEC
Apr 7, 2021Ra Capital Management, L.P.13GOld format–New–SEC
Feb 19, 2021Citadel Advisors LLC13GOld format–New–SEC
Feb 18, 2021Vivo Capital VIII, LLC13GOld format–New–SEC
Feb 17, 2021Pivotal bioVenture Partners Fund I, L.P.13DOld format–New–SEC
Feb 16, 2021Sofinnova Venture Partners X, L.P.13DOld format–New–SEC
Feb 11, 2021Novo Holdings A/S13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Bolt Biotherapeutics, Inc. shares.

No Form 144 notices for Bolt Biotherapeutics, Inc. are on file.